2016 American Transplant Congress
Effect of Isolated Intraperitoneal Sirolimus Treatment on the Kidneys of C57BL/6 Mice.
Sirolimus, a mammalian target of rapamycin inhibitor, is widely used in transplantation. However, the mechanism by which sirolimus induces adverse effects such as proteinuria and…2016 American Transplant Congress
Development of Diabetic Glomerulosclerosis (DMGS) After Kidney Transplantation (KTX).
Transplant Center, Mayo Clinic, Rochester, MN.
Introduction. Causes of death-censored KTX loss are multiple and often non-alloimmune mediated. Examination of KTX biopsies after 5 years revealed an increasing number of cases…2016 American Transplant Congress
Risk of Acute Rejection Among ABO Incompatible Living Donor Kidney Recipients.
School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Background: ABO incompatible (ABOi) live donor kidney transplantation (LDKT) holds the potential for increased access to transplantation for ESRD patients. Concerns remain related to the…2016 American Transplant Congress
Post-Donation eGFR and Hypertension in Living Kidney Donors.
1JHU, Baltimore; 2University of Alabama, Birmingham, Birmingham.
Donor eGFR declines sharply after living kidney donation, but long-term eGFR trajectories and their relationship to post-donation hypertension are poorly understood.METHODS: We retrospectively obtained 7805…2016 American Transplant Congress
Incidence of Post-Transplant Cardiovascular Disease After Pediatric Kidney Transplantation.
PURPOSE: Kidney transplant (KTx) recipients have increased risk of cardiovascular disease (CVD), related to time on dialysis and post-KTx immunosuppression. To date, the incidence of…2016 American Transplant Congress
Incidence and Renal Consequences of Type 2 Diabetes Mellitus in Kidney Donors.
Diabetes Mellitus (DM) continues to be the most common cause of kidney disease. The incidence of DM following kidney donation is unknown. Moreover, whether its…2016 American Transplant Congress
Survey Results Show Strong Support for Allowing Patients Undergoing Desensitization to Keep Their Pre-Desensitization CPRA Allocation Priority.
1UNOS, Richmond; 2Emory Univ Hosp, Atlanta; 3Stanford Univ, Palo Alto.
Background: On the waitlist, highly sensitized kidney (KI) candidates who undergo desensitization (DS) lose allocation priority associated with pre-DS CPRA value if some unacceptable antigens…2016 American Transplant Congress
Characteristics Independently Associated with Kidney Candidates Having CPRA of 99-100%.
Background: The new Kidney Allocation System (KAS) implemented on 12/4/14 included an increased allocation priority for candidates with CPRA 99-100%. On 11/30/14, just days prior…2016 American Transplant Congress
After Alemtuzumab Induction, Tac+MMF Is Superior to CsA+MMF in Pediatric Kidney Transplantation.
1Boris Petrovsky SCS, Moscow, Russian Federation; 2Mount Sinai Hospital, New York, NY.
Introduction: Recipient parenchymal lymphatic cells are crucial for direct and indirect pathways of allorecognition. We proposed that administering alemtuzumab several weeks pretransplantation could eradicate peripheral…2016 American Transplant Congress
A Pilot Study of Donor: A Smart Phone Application for Identifying Live Kidney and Liver Donors.
Background: With over 100,000 candidates waiting, rates of deceased donation stagnant, and only 17,000 Kidney and liver transplants a year, live donor transplantation may represent…
- « Previous Page
- 1
- …
- 91
- 92
- 93
- 94
- 95
- …
- 101
- Next Page »